Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nymox Pharmaceuticals has reported a net loss of $5.2 million, or $0.18 per share for the year ended December 31, 2007, compared to $4.8 million, or $0.18 per share for same period in 2006.
Subscribe to our email newsletter
The increase in net losses for the year is attributable to increased expenditures in research and development of products in the company’s pipeline and to accounting requirements for stock option compensation. Product sales amounted to $412,923 for the year ended December 31, 2007, compared to $437,440 for the same period in 2006.